These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 4375631)
21. [Urinary excretion of c-AMP, as a parathyroid function test]. Samuel R; Scott D; Liberman UA Harefuah; 1986 Jun; 110(12):595-7. PubMed ID: 3023211 [No Abstract] [Full Text] [Related]
22. The acute effect of chlorothiazide on serum-ionized calcium. Evidence for a parathyroid hormone-dependent mechanism. Popovtzer MM; Subryan VL; Alfrey AC; Reeve EB; Schrier RW J Clin Invest; 1975 Jun; 55(6):1295-302. PubMed ID: 1133175 [TBL] [Abstract][Full Text] [Related]
23. Ionized calcium and cyclic AMP in plasma and urine. Biochemical evaluation in calcium metabolic disease. Thode J Scand J Clin Lab Invest Suppl; 1990; 197():1-45. PubMed ID: 2154030 [TBL] [Abstract][Full Text] [Related]
24. Urinary excretion of cyclic AMP in hyperparathyroidism. Wålinder O; Ljunghall S; Wibell L Scand J Urol Nephrol; 1978; 12(1):67-71. PubMed ID: 204993 [TBL] [Abstract][Full Text] [Related]
25. Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans. Taylor AL; Davis BB; Pawlson LG; Josimovich JB; Mintz DH J Clin Endocrinol Metab; 1970 Mar; 30(3):316-24. PubMed ID: 4312793 [No Abstract] [Full Text] [Related]
26. Effect of synthetic 1-34 fragment of human parathyroid hormone on plasma adenosine 3',5'-monophosphate (cAMP) concentrations and the diagnostic criteria based on the plasma cAMP response in Ellsworth-Howard test. Sohn HE; Furukawa Y; Yumita S; Miura R; Unakami H; Yoshinaga K Endocrinol Jpn; 1984 Feb; 31(1):33-40. PubMed ID: 6329666 [TBL] [Abstract][Full Text] [Related]
28. [A new technic to evaluate the sensitivity of the renal parathyroid hormone receptor in man]. Mallet E; de Menibus CH; Basuyau JP; Brunelle P C R Seances Soc Biol Fil; 1976; 170(5):1094-8. PubMed ID: 192424 [TBL] [Abstract][Full Text] [Related]
29. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia]. Iida S Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786 [TBL] [Abstract][Full Text] [Related]
30. [The effects of the parathyroid hormone, calcium and calcitonin on plasma and urinary C-nucleotides in parathyroid disorders (author's transl)]. Nakagawa H Nihon Naibunpi Gakkai Zasshi; 1979 Nov; 55(11):1437-51. PubMed ID: 230098 [No Abstract] [Full Text] [Related]
37. Urinary excretion of cyclic AMP in primary hyperparathyroidism. Bartley PC; Willgoss D; Lloyd HM Aust N Z J Med; 1975 Feb; 5(1):36-8. PubMed ID: 169778 [TBL] [Abstract][Full Text] [Related]
38. [Importance of the measurement of nephrogenic cAMP in primary hyperparathyroidism]. Traba M; Rapado A; de la Piedra C; Castrillo JM; Esbrit P Rev Clin Esp; 1982 May; 165(4):251-4. PubMed ID: 6291105 [No Abstract] [Full Text] [Related]
39. Parathyroid hormone infusion test in children and adolescents. Hochberg Z; Moses AM; Richman RA Miner Electrolyte Metab; 1984; 10(2):113-6. PubMed ID: 6321936 [TBL] [Abstract][Full Text] [Related]
40. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone. Connors MH; Irias JJ; Golabi M Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]